1 / 23

HIV/AIDS-Related Health Services in Substance Abuse Treatment Programs

HIV/AIDS-Related Health Services in Substance Abuse Treatment Programs. Authors & Affiliations Lawrence S. Brown, Jr, MD, MPH, Steven Kritz, MD, Edmund J. Bini, MD, MPH, Ben Louie, BA, Jim Robinson, MEd, Donald Alderson, MS, John Rotrosen, MD

lysandra-jarvis
Download Presentation

HIV/AIDS-Related Health Services in Substance Abuse Treatment Programs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV/AIDS-Related Health Services in Substance Abuse Treatment Programs Authors & Affiliations Lawrence S. Brown, Jr, MD, MPH, Steven Kritz, MD, Edmund J. Bini, MD, MPH, Ben Louie, BA, Jim Robinson, MEd, Donald Alderson, MS, John Rotrosen, MD Addiction Research and Treatment Corporation, Brooklyn, NY New York University School of Medicine / VA New York Harbor Healthcare System, New York, NY Nathan Kline Institute, Orangeburg, NY

  2. Disclosures There are no financial interests or other disclosures to report for any of the authors involved in this project

  3. Drug Abuse Treatment Clinical Trials Network 17 Nodes with 116 Community Treatment Programs Reaching into 26 States & DC Seattle Portland Detroit New York City Boston New Haven Denver Long Island Philadelphia Cincinnati San Francisco Baltimore/Richmond Raleigh/ Durham Albuquerque Los Angeles Charleston Miami CTN Sites (2003-2005)

  4. Study Sites • Northern New England Node: McLean Hospital, Belmont, MA • New England Node: Yale University, New Haven CT • New York Node: New York University, New York, NY • Long Island Node: NY State Psychiatric Institute, New York, NY • Delaware Valley Node:University of Pennsylvania, Philadelphia, PA • Mid-Atlantic Node: Johns Hopkins University, Baltimore, MD Medical College of Virginia, Richmond, VA • South Carolina Node: Medical University of South Carolina, Charleston, SC • North Carolina Node: Duke University, Raleigh/Durham, NC • Florida Node: University of Miami, Coral Gables, FL • Great Lakes Node: Wayne State University, Detroit, MI • Ohio Valley Node: University of Cincinnati, Cincinnati, OH • Rocky Mountain Node: University of CO Health Sciences Center, Denver, CO • Southwest Node: University of New Mexico, Albuquerque, NM • Pacific Region Node: University of California at Los Angeles, Los Angeles, CA • California-Arizona Node: University of California at San Francisco, San Francisco, CA • Oregon Node: Oregon Health Sciences University, Portland, OR • Washington Node: University of Washington, Seattle, WA

  5. Background • HIV disease -- a major cause of morbidity & mortality, substantially associated with substance abuse. • Substance abuse treatment – recommended to reduce substance abuse-related HIV infection. • Little is known about how drug treatment programs reduce substance abuse-related HIV infection.

  6. Objectives To describe: • Characteristics of the substance abuse treatment programs • Characteristics of the patients served • Range of HIV-related services offered: • All patients • New admissions • HIV+ patients

  7. Methods • Study Design • Cross sectional survey • Descriptive exploratory • Study Population • Administrators at substance abuse treatment programs within the NIDA Clinical Trials Network

  8. Methods • Data Source: Survey instrument • Approved waiver of informed consent by Institutional Review Boards with jurisdiction over the participating treatment programs.

  9. The Survey Consisted of 112 questions divided into 8 sections: • Structure and Service Setting (6) • Patient Characteristics (3) • Staff Characteristics (10) • Reimbursement Issues (24) • Practices (30) • Program Guidelines (8) • Barriers (27) • Opinions (4)

  10. …more on the survey • Drug treatment program administrators were advised to describe: • Main clinical setting • Types of addiction services • Types of HIV-related services • They also were asked about: • Estimated HIV infection prevalence • Risk behaviors

  11. Results • The data derives from surveys submitted by administrators from 269 (84%) of 319 treatment programs within the CTN located in 26 states & DC • No portion of the country or the CTN was over-represented among the 50 non-responding programs

  12. About the treatment programs Approximately 80% of the treatment programs were private not-for-profit agencies The program types were: • 61%: free-standing facilities • 14%: hospitals, medical schools or universities • 13%: co-located in mental health, family health or child health centers • 12%: other types of healthcare facilities

  13. …more about the treatment programs • Most treatment programs offered two or more addiction treatment services • 88% offered outreach and support services • 80% had other outpatient services: detox, intensive outpatient, housing or aftercare • 55% offered inpatient detox or residential services • 37% provided outpatient pharmacotherapy services, such as methadone

  14. HIV-Related Treatment Services at Substance Abuse Treatment Programs

  15. HIV-Related Treatment Services at Substance Abuse Treatment Programs

  16. Mean Number of HIV-Related Treatment Services By Program and Patient Characteristics of Substance Abuse Treatment Programs

  17. Mean Number of HIV-Related Treatment Services By Program and Patient Characteristics of Substance Abuse Treatment Programs

  18. ...And… THERE IS MORE DATA

  19. Discussion • The results of this study provide a plausible mechanism of how substance abuse treatment reduces HIV transmission via the availability of: • HIV-related prevention services • HIV-related medical services • This provides the basis for: • future hypothesis-testing • health service studies examining the utilization, effectiveness, and cost-effectiveness of HIV-related health services provided by substance abuse treatment programs

  20. Discussion • This investigation highlighted four major findings: • Rates for HIV-related education, behavioral risk assessment and HIV testing are lower than authoritative guidelines • Hospital and university-based programs offered the most services • HIV-related services are higher in programs with higher HIV infection and risk behavior rates • A previous publication from this study showed that greater service availability can be achieved by drafting state guidelines and providing information on funding sources directly to the programs

  21. Limitations • This investigation did not include information about the costs, effectiveness or utilization of HIV-related services or patient satisfaction • It did not include data validating the information provided by treatment program administrators • Lack of random selection may impact generalizablility of the findings

  22. Conclusions Given the public health significance of HIV disease and the role of substance use in its transmission, further studies to examine the reasons for the wide variability of HIV-related service availability are warranted

  23. Acknowledgements Research supported by the National Institute on Drug Abuse (NIDA) as part of a Cooperative Agreement with the NIDA CTN (2U10DA013046). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NIDA CTN Other protocol team members are: Randy Seewald MD, Frank McCorry PhD, Dennis McCarty PhD, Donald Calsyn PhD, Leonard Handelsman MD, Steven Kipnis MD, Al Hassem MSW, Karen Reese CAC-AD, Sherryl Baker PhD, Cheryl Smith PhD, Shirley Irons, Kathlene Tracy PhD, Pat McAuliffe MBA, LADC

More Related